Of the $341 million increase in funding requested for the FDA in President Biden’s FY 2025 budget proposal, $114 million is needed to fund FDA employees’ 5 percent inflation pay increases for both this year and next, according to the agency’s chief financial officer (CFO).

Benjamin Moncars, the FDA’s chief financial officer, spoke during the Alliance for a Stronger FDA’s webinar on Monday, saying the federal government granted employees the pay increase, but didn’t provide the $105 million in funding for it. So, since Jan. 1, the agency has had to shift funding away from various programs and stop hiring efforts to afford the raises.

If the lack of funding continues, “This will have a devastating and challenging impact for FDA centers and offices,” said Moncars, who added the FDA would really appreciate support from Congress on the matter.

To read the whole story, click here.

Related Topics